90553103 - REVATIS REGENERATIVE MEDICINE AND CELL THERAPY

Information

  • Trademark
  • 90553103
  • Serial Number
    90553103
  • Registration Number
    6742715
  • Filing Date
    March 01, 2021
    4 years ago
  • Registration Date
    May 31, 2022
    2 years ago
  • Transaction Date
    May 31, 2022
    2 years ago
  • Status Date
    May 31, 2022
    2 years ago
  • Published for Opposition Date
    March 15, 2022
    3 years ago
  • Location Date
    May 31, 2022
    2 years ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    AGOSTO, GISELLE MARIE
  • Attorney Docket Number
    5267.232
    Attorney Name
    Nicholas D. Wells
    Law Office Assigned Location Code
    L20
  • Owners
Mark Drawing Code
3000
Mark Identification
REVATIS REGENERATIVE MEDICINE AND CELL THERAPY
Case File Statements
  • GS0401: Cell cryopreservation services
  • DM0000: The mark consists of a blue rectangular carrier in which appears the stylized wording "REVATIS" where "REVA" appears in green and "TIS" appears in white with the letter "I" formed by three vertically aligned white dots; below this wording appears the smaller stylized white wording "REGENERATIVE MEDICINE AND CELL THERAPY".
  • GS0051: Pharmaceutical products for regenerative medicine; orthopedic articles, namely, lubricating gel
  • CC0000: The color(s) blue, green and white is/are claimed as a feature of the mark.
  • GS0441: Veterinary services; Beauty and hygiene care services for animals; Skin care services being hygiene and beauty care; medical services
  • GS0101: Medical apparatus and instruments for veterinary purposes and for use in surgery as it relates to regenerative medicine; cell culture apparatus for medical or veterinary use, namely, cell culture chambers; orthopedic articles, namely, bone prostheses, joint prostheses, medical instruments for use in performing biopsies in the nature of microbiopsies
  • D10000: "REGENERATIVE MEDICINE AND CELL THERAPY"
  • GS0421: Development of pharmaceutical products; development of cell therapy products; development of technologies for the manufacture and processing of cells for use in advanced cell therapy; Research and development of new products for others
Case File Event Statements
  • 5/31/2022 - 2 years ago
    22 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC
  • 5/31/2022 - 2 years ago
    21 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 3/15/2022 - 3 years ago
    20 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 3/15/2022 - 3 years ago
    19 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 2/23/2022 - 3 years ago
    18 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 2/10/2022 - 3 years ago
    17 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV
  • 2/8/2022 - 3 years ago
    16 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 2/8/2022 - 3 years ago
    15 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 2/8/2022 - 3 years ago
    14 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 2/8/2022 - 3 years ago
    13 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 2/8/2022 - 3 years ago
    12 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 2/8/2022 - 3 years ago
    11 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 2/8/2022 - 3 years ago
    10 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 2/1/2022 - 3 years ago
    9 - ASSIGNED TO LIE Type: ALIE
  • 1/28/2022 - 3 years ago
    8 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 9/22/2021 - 3 years ago
    7 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 9/22/2021 - 3 years ago
    6 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 9/22/2021 - 3 years ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 9/22/2021 - 3 years ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 6/1/2021 - 3 years ago
    3 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSC
  • 5/30/2021 - 3 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS
  • 3/4/2021 - 4 years ago
    1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP